Bristol-Myers Squibb buy fenjal
Start price
01.05.24
/
50%
€41.10
Target price
01.05.25
-
Performance (%)
11.46%
End price
26.07.24
€45.81
Summary
This prediction ended on 26.07.24 with a price of €45.81. The BUY prediction by fenjal finished with a performance of 11.46%. A total of €0.55 was paid as dividends for this prediction. fenjal has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bristol-Myers Squibb | 4.248% | 4.248% | -16.940% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
According to fenjal what are the pros and cons of Bristol-Myers Squibb for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Cons
Comments by fenjal for this prediction
In the thread Bristol-Myers Squibb diskutieren
Buy Bristol-Myers Squibb
In the thread Trading Bristol-Myers Squibb
Buy beendet
Stopped prediction by fenjal for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€42.35
23.04.25
23.04.25
-
23.04.26
23.04.26
-0.53%
25.11.25
25.11.25
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€47.60
05.01.24
05.01.24
-
05.01.25
05.01.25
0.63%
05.03.24
05.03.24
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€68.08
03.01.23
03.01.23
-
03.01.24
03.01.24
-32.29%
28.12.23
28.12.23
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€66.35
25.03.22
25.03.22
-
25.04.22
25.04.22
6.07%
26.04.22
26.04.22
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€49.48
19.06.20
19.06.20
€55.00
04.11.21
04.11.21
12.05%
04.04.21
04.04.21
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€41.54
18.04.19
18.04.19
€52.32
09.06.20
09.06.20
30.00%
09.06.20
09.06.20
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating


